{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG|Designated/Withdrawn" in comments (approximate match)
Status:
Investigational
Source:
INN:tamrintamab pamozirine [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00087022: Phase 3 Interventional Completed Kidney Cancer
(2004)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01802814: Phase 3 Interventional Completed Acute Lymphoblastic Leukemia (ALL)
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02898753: Phase 1/Phase 2 Interventional Terminated Pompe Disease
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02979899: Phase 3 Interventional Completed Advanced Angiosarcoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03821233: Phase 1 Interventional Completed HER2-expressing Cancers
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04256148: Phase 2 Interventional Withdrawn Warm Autoimmune Hemolytic Anemia
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03296696: Phase 1 Interventional Terminated Glioblastoma or Malignant Glioma
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03481946: Phase 1 Interventional Completed Hemophilia A; Hemophilia B
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04543344: Phase 1 Interventional Completed Healthy
(2020)
Source URL:
Class:
PROTEIN
